CHRISTOPHER M. STARR - 02 Feb 2022 Form 4 Insider Report for Monopar Therapeutics (MNPR)

Role
Director
Signature
/s/ Kim R. Tsuchimoto, Attorney-in-fact
Issuer symbol
MNPR
Transactions as of
02 Feb 2022
Net transactions value
$0
Form type
4
Filing time
04 Feb 2022, 18:35:38 UTC
Previous filing
04 Jan 2022
Next filing
01 Apr 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MNPR Stock Options Award $0 +15,128 $0.000000 15,128 02 Feb 2022 Common Stock 15,128 $2.80 Direct F1
transaction MNPR Restricted Stock Options Award $0 +11,436 $0.000000 11,436 02 Feb 2022 Common Stock 11,436 $0.000000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options vest 25% quarterly on March 31, 2022, June 30, 2022, September 30, 2022 and December 31, 2022.
F2 RSUs vest 25% quarterly on March 31, 2022, June 30, 2022, September 30, 2022 and December 31, 2022.